Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.


Recent & Breaking News (NYSEAM:ZOM)

Zomedica Pharmaceuticals Corp. Announces Public Offering

GlobeNewswire April 7, 2020

Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results

GlobeNewswire February 26, 2020

Zomedica Announces Completion of $2.5 Million Registered Direct Offering

GlobeNewswire February 14, 2020

Zomedica Announces $2.5 Million Registered Direct Offering

GlobeNewswire February 12, 2020

Zomedica Files U.S. Patent Application for Fecal Parasite Detection

GlobeNewswire February 11, 2020

Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020

GlobeNewswire January 30, 2020

Zomedica to Focus on TRUFORMA(TM) Commercialization

GlobeNewswire January 23, 2020

Zomedica Successfully Completes Development and Manufacturing Milestones for its Cancer Liquid Biopsy Platform

GlobeNewswire January 20, 2020

Zomedica Announces Management Changes

GlobeNewswire December 3, 2019

Zomedica Expands ZM-006 Pilot Efficacy Study

GlobeNewswire November 13, 2019

Zomedica Announces Third Quarter 2019 Financial Results

GlobeNewswire November 12, 2019

Zomedica Announces 2019 Annual Meeting Results

GlobeNewswire November 5, 2019

Zomedica Commences Final TRUFORMA(TM) Diagnostic Verification Study

GlobeNewswire October 31, 2019

CORRECTION FROM SOURCE: Zomedica Pushes TRUFORMA(TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market

Newsfile October 3, 2019

Zomedica Pushes TRUFORM (TM) Closer To Commercialization, Targeting $2.7 Billion Companion Animal Diagnostics Market

Newsfile October 1, 2019

PCG Research Announces Publication of Report Covering Zomedica Pharmaceuticals Corp.

Newsfile September 11, 2019

Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City

Accesswire September 11, 2019

Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference

GlobeNewswire September 3, 2019

Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors

GlobeNewswire August 19, 2019

Zomedica Inc. Prepares to Launch Veterinarian Diagnostic Device, TRUFORMA(TM); Has Potential to Change Diagnostic Landscape in Animal Health (NYSE American: ZOM)

Accesswire August 13, 2019